We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
825
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FICO icon
201
Fair Isaac
FICO
$22.6B
$2.9M 0.08%
5,773
+4,172
+261% +$2.11M
MDT icon
202
Medtronic
MDT
$111B
$2.88M 0.08%
23,213
-111,288
-83% -$14M
PKG icon
203
Packaging Corp of America
PKG
$22.4B
$2.88M 0.07%
21,246
+9,735
+85% +$1.4M
STNE icon
204
StoneCo
STNE
$2.76B
$2.88M 0.07%
42,927
+39,339
+1,096% +$2.55M
TWTR
205
DELISTED
Twitter, Inc.
TWTR
$2.87M 0.07%
41,755
-53,763
-56% -$3.3M
PM icon
206
Philip Morris
PM
$292B
$2.86M 0.07%
28,815
-93,776
-76% -$9M
CTLT
207
DELISTED
CATALENT, INC.
CTLT
$2.85M 0.07%
26,312
+9,277
+54% +$994K
TEAM icon
208
Atlassian
TEAM
$28B
$2.82M 0.07%
10,980
-171
-2% -$40K
TXG icon
209
10x Genomics
TXG
$5.97B
$2.79M 0.07%
14,273
-1,452
-9% -$263K
KDP icon
210
Keurig Dr Pepper
KDP
$42.1B
$2.79M 0.07%
79,142
-25,357
-24% -$905K
PAYX icon
211
Paychex
PAYX
$41.9B
$2.76M 0.07%
25,743
-18,491
-42% -$1.86M
IHI icon
212
iShares US Medical Devices ETF
IHI
$3.36B
$2.76M 0.07%
45,882
-122,970
-73% -$7.11M
ZM icon
213
Zoom
ZM
$28.8B
$2.76M 0.07%
7,134
-16,230
-69% -$5.41M
DHR icon
214
Danaher
DHR
$139B
$2.76M 0.07%
11,583
-48,044
-81% -$10.7M
MTCH icon
215
Match Group
MTCH
$9.46B
$2.74M 0.07%
17,014
-4,920
-22% -$721K
VOE icon
216
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$2.74M 0.07%
19,505
+19,369
+14,242% +$2.74M
TECH icon
217
Bio-Techne
TECH
$11.2B
$2.73M 0.07%
24,280
+19,436
+401% +$2.05M
IPO icon
218
Renaissance IPO ETF
IPO
$162M
$2.7M 0.07%
40,811
+1,951
+5% +$121K
SPHD icon
219
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.4B
$2.7M 0.07%
+61,251
New +$2.73M
IYY icon
220
iShares Dow Jones US ETF
IYY
$3.05B
$2.69M 0.07%
24,897
+24,356
+4,502% +$2.56M
FDS icon
221
Factset
FDS
$9.59B
$2.68M 0.07%
7,976
+511
+7% +$167K
XLY icon
222
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
$2.67M 0.07%
29,934
-280,700
-90% -$24.4M
MSCI icon
223
MSCI
MSCI
$41.8B
$2.67M 0.07%
5,006
-2,651
-35% -$1.26M
CERN
224
DELISTED
Cerner Corp
CERN
$2.66M 0.07%
34,068
-11,771
-26% -$906K
VIOG icon
225
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.09B
$2.65M 0.07%
+23,140
New +$2.6M

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 825 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.